What is Leerink Partnrs’ Forecast for Vaxcyte Q3 Earnings?
Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) – Investment analysts at Leerink Partnrs raised their Q3 2025 EPS estimates for Vaxcyte in a research note issued to investors on Wednesday, May 7th. Leerink Partnrs analyst D. Risinger now forecasts that the company will earn ($1.22) per share for the quarter, up from their prior estimate of […]
